&& 查看话题
SCI录用的最后一步——答复审稿人的策略和答复信的写作技巧
一篇稿子从酝酿到成型历经艰辛，投出去之后又是漫长的等待，好容易收到编辑的回信，得到的往往又是审稿人不留情面的一顿狂批。这时候，如何有策略有技巧的回复审稿人就显得尤为重要。好的回复是文章被接收的重要砝码，而不恰当的回复轻则导致再次修改从而拖延发稿时间，重则导致文章被拒，前功尽弃。下面把我平时总结的一些答复审稿人的策略和写回复信的格式和技巧跟大家交流一下。
首先，绝对服从编辑的意见。在审稿人给出各自的意见之后，编辑一般不会再提出自己的意见。但是，编辑一旦提出某些意见，就意味着他认为这是文章里的重大缺陷，至少是不合他的口味。这时，我们唯一能够做的只能是服从。因为毕竟是人家掌握着生杀予夺的大权。
第二，永远不要跟审稿人争执。跟审稿人起争执是非常不明智的一件事情。审稿人意见如果正确那就不用说了，直接照办就是。如果不正确的话，也大可不必在回复中冷嘲热讽，心平气和的说明白就是了。大家都是青年人，血气方刚，被人拍了当然不爽，被人错拍了就更不爽了。尤其是一些名门正派里的弟子，看到一审结果是major而不是minor本来就已经很不爽了，难得抓住审稿人的尾巴，恨不得拖出来打死。有次审稿，一个审稿人给的意见是增加两篇参考文献（估计也就是审稿人自己的文章啦），结果作者在回复中写到，making a reference is not charity！看到之后我当时就笑喷了，可以想象审稿人得被噎成什么样。正如大家所想的那样，这篇稿子理所当然的被拒了，虽然后来经编辑调解改成了major revision，但毕竟耽误的是作者自己的时间不是？
第三，合理掌握修改和argue的分寸。所谓修改就是对文章内容进行的修改和补充，所谓argue就是在回复信中对审稿人的答复。这其中大有文章可做，中心思想就是容易改的照改，不容易改的或者不想改的跟审稿人argue。对于语法、拼写错误、某些词汇的更换、对某些公式和图表做进一步解释等相对容易做到的修改，一定要一毫不差的根据审稿意见照做。而对于新意不足、创新性不够这类根本没法改的，还有诸如跟算法A，B，C，D做比较，补充大量实验等短时间内根本没法完成的任务，我们则要有理有据的argue。在Argue的时候首先要肯定审稿人说的很对，他提出的方法也很好，但本文的重点是blablabla，跟他说的不是一回事。然后为了表示对审稿人的尊重，象征性的在文中加上一段这方面的discussion，这样既照顾到了审稿人的面子，编辑那也能交待的过去。
第四，聪明的掌握修改时间。拿到审稿意见，如果是minor，意见只有寥寥数行，那当然会情不自禁的一蹴而就，一天甚至几小时搞定修改稿。这时候，问题在于要不要马上投回去了？我的意见是放一放，多看一看，两个星期之后再投出去。这样首先避免了由于大喜过望而没能及时检查出的小毛病，还不会让编辑觉得你是在敷衍他。如果结果是major，建议至少放一个月再投出去，显得比较郑重。
上面是一些一般性的答复审稿人的策略，在实际中的应用还需要大家见仁见智。下面谈谈答复信的写法。
写答复信的唯一目的是让编辑和审稿人一目了然的知道我们做了哪些修改。因此，所有的格式和写法都要围绕这一目的。一般来说可以把答复信分成三部分，即List of Actions, Responses to Editor, Responses to Reviewers。第一部分List of Actions的作用是简明扼要的列出所有修改的条目，让编辑和审稿人在第一时间对修改量有个概念，同时它还充当着修改目录的作用，详见下面的例子。剩下的两部分是分别对编辑和审稿人所做的答复，格式可以一样，按照“意见”－“argue”（如果有的话）－“修改”这样逐条进行。清楚醒目起见，可以用不同字体分别标出，比如“意见”用italic，“argue”正常字体，“修改”用bold。下面举例说明各部分的写法和格式。
编辑意见：请在修改稿中用双倍行距。
& & & & 意见1：置疑文章的创新性，提出相似的工作已经被A和B做过。
& & & & 意见2：算法表述不明确。
& & & & 意见3：对图3的图例应做出解释。
& & & & 意见1：图2太小。
& & & & 意见2：第3页有个错别字。
很显然，根据上面的答复策略，我们准备对除1号审稿人意见1之外的所有意见进行相应改动，而对1.1采取argue为主的策略。答复如下：
List of Actions
LOA1: The revised manuscript is double spaced.
LOA2: A discussion on novelty of this work and a comparison with A and B have been added in page 3.
LOA3: A paragraph has been added in page 5 to further explain the algorithm ***.
LOA4: Explanations of the legend of Figure 3 have been added in page 7.
LOA5: Figure 2 has been enlarged.
LOA6: All typos have been removed.
==================分页=======================
Responses to Editor
请在修改稿中用双倍行距。
We have double spaced the text throughout the revised manuscript, see LOA1.
==================分页=======================
Responses to Reviewers
To Reviewer 1:
意见1：置疑文章的创新性，提出相似的工作已经被A和B做过。
Thank you for pointing this out. A and B’s research groups have done blablablabla. However, the focus of our work is on blablablabla, which is very different from A and B’s work, and this is also the major contribution of our work. We have added the following discussion on this issue in our revised manuscript, see LOA2.
“blablablabla(此处把A和B的工作做一个review，并提出自己工作和他们的区别之处)”
意见2：算法表述不明确。
We have added the following discussion to further explain algorithm ***, see LOA3.
“blablablabla（此处进一步解释该算法）”
意见3：对图3的图例应做出解释。
We have added the following explanations of the legend of Figure 3, see LOA3.
“blablablabla（图3图例的解释）”
==================分页=======================
To Reviewer 2:
意见1：图2太小。
We have enlarged Figure 2, see LOA 4.
意见2：第3页有个错别字。
We have removed all typos, see LOA5.
==================分页=======================
总之，写答复信的宗旨就是用最少的时间和工作量达到论文被接收的目的。这里权当是抛砖引玉，希望和大家多多交流。
＝＝＝版权所有pitlord999@小木虫，转载请注明出处===========
支持鼓励，加油 很实在，以后要把握分寸了！ 好的很啊，谢谢啦。。。 Good to learn. 说得好&&学习 very good! 学习学习！ 很不错的主题 很有用，谢谢！ 学习！
感谢分享:D 学习了，谢谢给的好经验！ 学习了.:):):):) :D
比我那个详细哈 我都没注意到写了这么好的经验，否则我就不写了赫赫 Originally posted by csfn at
比我那个详细哈 我都没注意到写了这么好的经验，否则我就不写了赫赫 共勉共勉:D:D:D:D
var cpro_id = 'u1216994';
欢迎监督和反馈：本帖内容由
提供，小木虫仅提供交流平台，不对该内容负责。欢迎协助我们监督管理，共同维护互联网健康，如果您对该内容有异议，请立即发邮件到
联系通知管理员，也可以通过QQ周知，我们的QQ号为：8835100
我们保证在1个工作日内给予处理和答复，谢谢您的监督。
小木虫，学术科研第一站，为中国学术科研研究提供免费动力
广告投放请联系QQ： &
违规贴举报删除请联系邮箱： 或者 QQ:8835100
Copyright &
eMuch.net, All Rights Reserved. 小木虫 版权所有经验内容仅供参考，如果您需解决具体问题(尤其法律、医学等领域)，建议您详细咨询相关领域专业人士。
我有疑问(0)
说说为什么给这篇经验投票吧！
我为什么投票...
你还可以输入500字
看了这篇经验，你有一些独到的心得要分享给大家?或是，你按照作者的指导，做出了一模一样，甚至更棒的结果？
不管是“有心得”，还是“有所得”，都快分享给经验的小伙伴们看看吧！
非回享用户暂时不能发布经验“有得”&
你还可以输入1000字
如对这篇经验有疑问，可反馈给作者，经验作者会尽力为您解决！
你还可以输入500字
请扫描分享到朋友圈&& 查看话题
SCI论文写作，大家是先写中文，然后再翻译吗？
SCI论文写作，大家是先写中文，然后再翻译吗？&&感觉直接写英语思路衔接不上啊。
直接英文。先提纲，再内容。写多了就习惯了，而且效率也会越来越高。 个人觉得直接写英文，最好不要翻译！ 要是英语水平可以的话，直接用英文是最好的 建议楼主直接用英语写作，先把文章的要点罗列出来，然后再加以扩展，成为一篇文章，如果碰到想不起来的英语单词可以先空着，最好能够提纲一气呵成。写完了以后，可以放几天再修改。之后就是找导师或者发过文章的师兄师姐帮忙润色文章了。 直接写英文绞尽脑汁啊。 多找些和你文章类似的文章，多模仿，建议楼主直接用英语写作，先把文章的要点罗列出来，然后再加以扩展，成为一篇文章 多看看相关的英文文献直接用英文写:hand: 赞一个，多谢大侠们：） 建议直接上英文
先打好自己的架构。一开始当然是巨痛苦无比，但是写多了自然自己就熟了 要是直接英文也可以啊。。。 一定直接英文 多看文章就知道怎么写了，翻译可不是件容易的事，不如直接写英文 直接写，有些语言表达用英语更方便。 直接英语最好，快，效率高了 真想练水平的话还是直接上英文吧 准备写文章，也在纠结这个问题 多看看别人的论文，直接用英文写。 :hand::hand:
var cpro_id = 'u1216994';
欢迎监督和反馈：本帖内容由
提供，小木虫仅提供交流平台，不对该内容负责。欢迎协助我们监督管理，共同维护互联网健康，如果您对该内容有异议，请立即发邮件到
联系通知管理员，也可以通过QQ周知，我们的QQ号为：8835100
我们保证在1个工作日内给予处理和答复，谢谢您的监督。
小木虫，学术科研第一站，为中国学术科研研究提供免费动力
广告投放请联系QQ： &
违规贴举报删除请联系邮箱： 或者 QQ:8835100
Copyright &
eMuch.net, All Rights Reserved. 小木虫 版权所有加载中，请稍候...
加载中，请稍候...
京 东 价：
￥21.00 [7.5折][定价：￥28.00]
温馨提示：
其它类似商品
正在加载中，请稍候...
正在加载中，请稍候...
正在加载中，请稍候...
SCI论文写作和发表：You Can Do It
查找同类商品
　　《SCI论文写作和发表：You
It》先整体概述了论文写作和发表的一般流程，例如如何写好一篇稿件、稿件修改、选择期刊和投稿之后、审稿人评价稿件标准等内容。然后对稿件各部分，如标题、摘要、简介、结果讨论等的撰写格式给出了具体建议和示例。后半部分对英文科技写作中的常用语法、词汇进行了具体剖析和举例，以切实提高读者的英文写作能力。
论文的写作和发表1.1
如何写好一篇稿件1.2
稿件修改1.3
选择期刊和投稿之后1.4
审稿人评价稿件标准第2章
稿件的撰写格式2.1
Affiliation
Information2.2
Abstract2.3
Introduction2.5
Experimental
Section2.6
Results2.7
Discussion2.8
Conclusion2.9
Acknowledgments2.10
References2.11
Letter第3章
英文写作3.1
论文写作中常出现的语法问题3.1.1
主语和谓语的单数和复数要一致3.1.2
修饰语同主语名词关系上要一致3.1.3
主语和主语的行动（谓语）在逻辑上要一致3.1.4
代名词和其代理的先行词要一致3.1.5
位置的强调作用3.1.6
修饰词和被修饰词要邻近3.1.7
主语和谓语在句子中的位置要靠近3.1.8
名词作形容词3.1.9
句子的时态3.1.10
主动句和被动句3.1.11
标点符号的使用3.1.12
数字的写法3.1.13
冠词的使用3.1.14
同位词的使用3.1.15
多余的用词3.1.16
隔离3.1.17
句子的连接和信息的传承3.2.1
信息的传承3.2.2
句子的连接3.2.3
平行句的组织方法3.2.4
写简单句子3.3
中式英文第4章
常用词汇4.1
经常使用但容易出现问题的字4.2
用以描写研究课题的意义和重要性4.3
用以描述某个领域的现状或作者的研究计划4.4
用以描述需要解决的问题4.5
有关过去和现在时间的词汇4.6
用于举例的词汇4.7
用以描述实验部分的词汇4.8
用于描写先后顺序的词汇4.9
描写实验结果的词汇4.10
用于比较语句的词汇4.11
用于讨论和描述实验意义的词汇4.12
常用的修饰词附：稿件样本附录
　　我们的烦恼　　俊东是高我一级的学长，也是我的好朋友。记得当年在北医药学系读书时与俊东熟悉是在1984年暑假去山东的夏令营中，经过十几天的“同居”，我俩性格相近，又是山东同乡，自然就成了无话不谈的哥们。以后俊东和我先后在药学系不同的课题组读硕士，后来俊东考了个很高的TOEFL成绩去美国攻读博士学位去了，之后我们的联系也就少了！我在硕士二年级参加考试转博，博士毕业后就留校任教。从讲师、副教授到教授，2001年被聘为博士生导师，按时晋升，没受到丝毫挫折。慢慢有了自己的课题组，招收了若干研究生，也在国内糖化学界有了一点知名度。和众多“海龟”相比，我应该算是“混”得好的“土鳖”了。“土鳖”们虽然生命力比较强，也服水土，但也有许多烦恼，缺钱、缺空间、招生名额太少等等，其中一个不大不小的烦恼是如何把自己的工作写成SCI文章并发表在相应档次的期刊上。　　中国人学习英文应该是最认真、花费时间也最久的，但“实用性”却不理想。我们许多人就是这种“全民英语工程”的产品，语法很熟，词汇量也不小，对学生写出来的论文改了又改，但投出去在内容得到肯定后，经常会得到一句“The
manuscript
scientific
English”的评价，这种情况一直伴随着我们，影响着论文发表的速度、档次，有时甚至会被拒稿。2008年俊东回国探亲，我们又团聚了，了解到俊东在业余时间干了两件事。一是成立了一个专业的编译团队，帮助国内的学者修改、润色论文，并且成绩斐然。这对我简直是一个天大的喜事，解决了我们课题组的大问题。几年来在俊东及其团队的帮助下，我们组的SCI论文发表速度明显加快，档次稳步提升，数量也上来了，现在每年能在20篇以上。更重要的是，通过俊东的帮助，我和学生们在SCI论文的写作上也有了不小的收获，几名博士生通过修改、发表论文，写作水平得到提升，赴美留学后论文的撰写基本没有问题。　　英文论文写作有它的规律和技巧，要达到专业的水平需要长期的训练和时间，并不是语言好就一定能写出好文章，中文论文的写作也是同样的道理。我了解到许多“海龟”甚至我们眼中很高的“大牛”们其论文也要请外籍人士或专业编辑来修改。在国际上，请专业编辑人才修改英文写作是学术界已普遍接受的一个通常做法，这一点国内也逐渐在接受。　　俊东做的另一件事是“著书立说”，他结合自己多年SCI论文写作和修改、润色的经验，写了这本“SCI论文写作和发表：You
It”。俊东是个学者，他的专业横跨了化学、药学和生物学，他做过研究，发过文章。从中国到美国的经历，他了解中国学者英文写作的瓶颈在哪里！除了帮助大家修改论文外，他还打算从年轻人的培养做起。现在国内的青年学生都有很好的英文水平，如果能有一本实用、针对性强的手册指导，借以时日，经过几轮实战的训练，定能写出与研究水平相当的SCI论文发表！　　俊东做了一件十分有意义的事情！　　李中军　　日于北大医学部
正在加载中，请稍候...
正在加载中，请稍候...
正在加载中，请稍候...
正在加载中，请稍候...
正在加载中，请稍候...
正在加载中，请稍候...
正在加载中，请稍候...
七日畅销榜
新书热卖榜SCI论文写法攻略
&SCI&& SCI&1. 2. 3. &&4. 5. &&6. 1. 2. (Dirac)&&199824SCI&&SCI 2070903. ①②SCIISISCI(Lists of Source Publications)ISI (Journal Citation ReportsJCR) (JCR on the Web) (JCR on CD-ROM)③ISI(Essential Science Indicators)(ISI )④ideaideaideaidea1. ideaideaA. B. C. D. E. 2. ideaidea3. ideaA. B. 60030010050C. reviewarticle1020review(1)()(2)(3)()(4)SCI-34. ideapatiencepassion5naturescience1. paperpostdocpapervolunteerphd symposiumseminarpapertopicpostdoc 2. IDEA:A. bird eye B. bird eyeideaideaC. special studybird eye D. ideaideaweaknessideapaperE. bird eyecopywalk around a little bitnew idea F. ()ideaidea&& SCITitle: Be short, accurate, Give your paper a
Begin with the subject of the study.IntroductionW W Why we did this study?MethodsParticipants, M Outcomes and e Statistical methods.ResultsSa U B Multivariate analyses.Tables and figuresNo more than s Use Table 1 for sample characteristics (no P values); Put most important findings in a figure.DiscussionS Outline the strengths and limi Discuss the relevance t Outline your implications with a clear &So what?& and &Where now?&ReferencesAll citati Include only the most important, most rigorous, and mo Quote only published journ Never quote &second hand&; Cite only 20-35 references.FormattingInclude the title, author, page numbers, etc. in Start each s Format titles and su Comply with &Instructions to authors&. 1. IntroductionA. HoweverHowever, little information(little attention/little work/little data/little research&&) (or few studies/few investigations/few researchers/few attempts&&) (or no/none of these studies&&) has (have) been done on (focused on/attempted to/conducted/investigated/studied(with respect to))Previous research (studies, records) has (have) failed to consider/ ignored/ misinterpreted/ neglected to/overestimated, underestimated/misleaded. thus, these previous results are inconclisive, misleading, unsatisfactory, questionable, controversial. Uncertainties (discrepancies) still exist&&However, data is still scarce(rare, less accurate)We need to(aim to, have to) provide more documents(data, records, studies, increase the dataset). Further studies are still necessary(essential)&& However(1)(2)(3)(4)(5)(However)&&(However)(However)uncertaintiesambiguities&&We aim to test the feasibility (reliability) of the&&It is hoped that the question will be resolved (fall away) with our proposed method (approach).B. We aim to//This paper reports on//This paper provides results//This paper extends the method//This paper focus on&&The purpose of this paper is to&&Furthermore, Moreover, In addition, we will also discuss&&C. introduction(reviewer)reviewer(1)(2) We preliminarily focus on the older (younger)&& (long-term and short term)D. &&further studies on&&will be summarized in our next study (or elsewhere)(arguments)2. DiscussionA. reviewer(1)We confirm that&&(2)We believe that&&(3)Results indicate, infer, suggest, imply that&&(4) We put forward(discover, observe)&&&for the first time&&&(5) We tentatively put forward (interrprete this to&)Or The results may be due to (caused by) attributed to resulted from&&Or This is probably a consequence of&&It seems that&&can account for (interpret) this&&Or It is posible that it stem from&&1)5)2)B. (1) However, also, in addition, consequently, afterwards, moreover, Furthermore, further, although, unlike, in contrast, Similarly, Unfortunately, alternatively, parallel results, In order to, despite, For example, Compared with, other results, thus, therefore&&AA advocated it for the first time.Then BB further demonstrated that. Afterwards, CC&&More recent studies by DD&&AA put forward that&&In contrast, BB believe or Unlike AA, BB suggest or On the contrary ()in contrast BB&&,AA suggest&&Similarily, alternatively, BB&&Or Also, BB or BB allso does&&Consequently, therefore, as a result&&furthermore, further, moreover, in addition&&(2) &&Therefore, there are three aspects of this problem have to be addressed. The first question involves&&The second problem relates to&&The third aspect deals with&&First, Second, Third, Finally&&Furthermore, in addition(3) C.(1)(2)(3) (1)It should be noted that this study has examined only&&We concentrate (focus) on only&&We have to point out that we do not&&Some limitations of this study are&&(2)The results do not imply&&The results can not be used to determine(or be taken as evidence of)&&Unfortunately, we can not determine this from this data&&Our results are lack of&&Not withstanding its limitation, this study does suggest&&However, these problems could be solved if we consider&&Despite its preliminary character, this study can clearly indicate&&3. OthersA. Abbreviation(1) AppendixAbbreviation(2)AbbreviationB. credits.negativeTheir results are wrong, very questionable, have no commensence, etc.Their studies may be more reasonable if they had&&considered this situation.Their results could be better convinced if they&&Or Their conclusion may remain some uncertanties.
5C(correctness)(clarity)(concision)(completion)(consistency) 51. IntroductionIntroduction(Discussion)IntroductionIntroductionIntroductionIntroductionIntroduction A. B. Introduction()() C. Introduction() D. Introduction IntroductionIntroduction 2. MethodsMethodsMethods4MethodsA. B. Discussion(calibration) C.
D. () 3. ResultsResultsDiscussion(Discussion)A. ResultsB. 8tifbmp(jpg)tifC. ResultsDiscussionResultsDiscussionD. Resultsp=0.02p&0.03SPSS 4. DiscussionIntroductionDiscussionDiscussionDiscussionA. ResultsDiscussionDiscussion B. (2)(1)(2)()() C. DiscussionResultsDiscussion 5. Acknowledge & References AcknowledgeNature Science Foundation of China(NSFC)National Institute of Health(NIH)(Grant Number)()editoranonymous reviewersReferences IntroductionMethodsResultsDiscussion Writing Skills in English for Research Paper paperPreparation, Structure, Title, Abstracts, Introduction, Conclusion, Body of Paper, Recision, AcknowledgementPreparationjournal in libraryStructurepaperstructuretriangle(wide)conclusionpaperbodydeclarative statementTitle(clearshort)topic(promote the interest of reader)titleabbreviationresultAbstractspaper(miniature of whole paper)(less than 200 words,one paragraph)paper(subject)(design)(procedures)(results) (non-specialist) Introduction(very relevant)bodydeclarative statementBodymethodsresultdiscussion①Methods(own procedures)subheadingssubsubsubsection②Resulttexttablefiguretablefigureresult③Discussionstudyproblemhypothesisconclusion&&& ConclusionbodyinformationbriefneatconcisepaperpaperprojectRevisondeclarative statementBrevity is the soul of literary constructionAcknowledgement(writing the first draft)(1) (methods and materials) (2) (results)(3) (discussion)&&(4) (references) (5) (introduction)(6) (acknowledgment)(7) (abstract)(&250)?()(8) (title)(accuracy)(brevity)(effectiveness) (9) (author list) (10) (preparing the final manuscript)&&(A poorly prepared manuscript isalmost without failthe carrier vehicle of poor science. Day AR.)&&&&&&(manuscript checklist, author's checklist) A. This paper describes &&The focus of this paper is &&Figure 1 shows &&Most of the common condensation polymers are listed in Table 1-1.B. ◆◆The catalyst concentrations for the different reactions are different.Our research focuses on the syntheses and characterizations of a series of polycarbonates with different chemical structures.The physical and chemical properties of this compound have been studied.The chain lengths of the oligomers with different molecular weights are different.◆◆Our research focuses on the synthesis of polycarbonates.The property of the compounds in group 1 is different from the property of the compounds in group 2.The chain length of the oligomers increases with increasing reaction time.◆◆PolyestersPolymers are macromolecules built up by large numbers of small molecules. The small molecules which combine with each other to form polymer molecules are termed monomers.Step CopolymerizationNewer Types of Step Polymerizations. This chapter will consider the characteristics of step polymerization in detail.◆◆ application&&&& development&&&& considerationcomposition&&&& concentration&&&& distributionstructure&&&& length&&&&&& weight◆◆()The reaction rate constant can be calculated from Equations 2 and 3. The reaction rate constant can be calculated from Equation 2 and Equation 3. Figs. 4 and 5 show &&C. ◆◆a , the This chapter will consider the characteristics of step polymerization in detail. An understanding of the relative ease of cyclization or linear polymerization comes from a variety of sources.Different polymers are synthesized to yield various mechanical behaviors by the appropriate combinations of crystallinity, crosslinking, Tg, and Tm..()Polyisoprene is a typical elastomer & it is amorphous, easily crossed, has a low Tg (-73&C) and a high Tm (14&C).◆◆1&&&& Introduction1-1&&&& Types of Polymers and Polymerizations&1-4 Molecular Weight1-5 Physical StateFig. 2-2 Second order plot of the self-catalyzed polyesterification of adipic acid with diethylene glycol at 166 &C.&&Fig. 8 Dependence of the ease of cyclization on the size of the ring.The polymerization is catalyzed by protonic or lewis acids although a wide variety of base catalysts such as calcium acetate and antimony trioxide can also be used.D. As discussed in Chapter 2, &&In Section 1.2, we &&As shown in Figure 1, &&The results are listed in Table 3.In the previous chapter, &&As shown in this figure, &&E. Figure&&&& Fig.&&&& Figures&&&&&& Figs.Table&&&&&& Tab.Chapter&&&& Chap.Section&&&& Sec.Equation&&&& Eq.&&&& Equations&&&& Eqs.F. ◆◆research, study, investigateresearchstudyinvestigate◆◆detail/detailedThe properties of this compound were studied in detail.//The detailed properties of this compound were studied.//The details of the properties of this compound were studied.◆◆follows/followingThe results are as follows: &&//We got following results: &&◆◆increase, decreaseWe can observe an increase in the reaction rate.//The reaction rate increases.◆◆focus, concentratefocus: n. , v. The focus of this paper is &&This paper focuses on &&Our study focuses on &&We focus our study on &&Our study is focused on &&concentrate: v. We concentrate our study on &&Our study is concentrated on &&◆◆effect, affecteffect: n. //affect: v.◆◆compose, consistA is composed of B and C.//A consists of B and C.◆◆increase, improveincrease: improve: G. &s
&& of && reaction ratereaction rate constantreaction temperaturereaction conditionmolecular weight distribution&&&& H. the reaction we studiedthe temperature usedthe nonlinearity observed&&of&&, &&&s
SCI:(1) SCISCI 3000 5600SCI(2) SCI(Impact Factor)2SCI1.00(3) SCI 1 / 3homepageInstruction for Author(Figure legends)Letter to editor-in-chief : ①②③④⑤⑥Faxe-mail⑦Title page Peroxisome Proliferation-Activated Receptor-g Ligands Ameliorate Experimental Autoimmune Myocarditis&Zuyi Yuan, MD, PhD; Yan Liu, MD; Yu Liu, MD; Jijun Zhang, MD; Chiharu Kishimoto, MD, PhD*; Yanni Wang, MD; Aiqun Ma, MD, PhD; Zhiquan Liu, MD. Department of Cardiovascular Medicine, First Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, C *Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, JapanFirst author's surname: YuanRunning head: PPARg ligands ameliorate myocarditis&Supported by Natural Science Foundation of China ()Address correspondence to:Zuyi Yuan, MD, PhDDepartment of Cardiovascular Medicine, First Hospital of Xi'an Jiaotong University,No.1 Jiankang Road, Xi'an, Shaanxi 710061, ChinaTel: +86-29-532-4021 Fax: +86-29-5263190E-mail: zuyiyuan@mail.A. (prestige)B. (1) (masthead statement)(2) (table of contents) (3) (4) (5) (submitted and accepted dates)(6) (7) 1112&&(statement of ownershipmanagementand circulation)(8) (9)
C. &&()&5C&&(correctness)(clarity)(concision)(completion)(consistency) D. (1) (covering lettersubmission letter)?()(corresponding author)e-mail()()(&&) Dear Dr Enclosed are three copies of a manuscript by Rose N DipaolaDonna AGalloand Tom NRoberts titled &Hepatitis C Virus Infection in Long-Term Transfusion Patients&. It is submitted to be considered for publication as a &Original Article& in your journalThis paper is?Neither the entire paper nor any part of its content has been published or has been accepted elsewhere. It is not being submitted to any other journal We believe the paper may be of particular interest to the readers of your journal because the study it reports stated the HCV infection rate among long-term transfusion patients is higher than that of the general population and of short-term transfusion patients Correspondence and phone calls about the paper should be directed to Rose NDipaola at the following addressphone and fax numberand e-mail address Rose N DipaolaMD &Institute of Internal Medicine Cleveland Clinic Foundation&&& 9500 Euclid Ave ClevelandOH44195USA Tel1-216-444-5360 Fax1-216-444-9580 E-maildipaocesmtp ccf. Org Thanks very much for your attention to our paper Sincerely yours Rose NDipaola (2) ()()() && (3) (&&)8.5x11?(hard copy)(fax)&&(e-mail)&&&&
SCI:&&&&(TheAstrophysicalJournal)Thomas&&(1) (follow-up correspondence)2email (2) (revised manuscript) (reviewers' comments)(covering letter)(modify letter)&& (3) (reviewer)(scientific priority)&&& (interesting)(response to reviewer123)(page, lines) []SCISCI?&&A :&&()(Solarphysics)HarveyHarvey&&B. && C &&& D SCIwell-writtenSaraMartinZwaanSCI(Science&Citation&IndexSCI)(Institute&for&Scientific&InformationISI)150SCISCISCI& &A :&()&SCI&50222SCIB. (1) SCISCI1997SCI10033&83%17%99.78%&0.09%&0.12%(2)SCISCI&&(3)SCISCIideaTitle&pageAbstractText&(Introduction&Methods&Results&Discussion)&ReferencesAcknowledgementsFigure&legendsTables&and&Figures()()115Discussion2SCI1.IF&32.3.IDEAeditorreviewer4.5.submissionguideline&for&authors6.point&to&pointaccept7.accept,simple&is&the&best()SCI(1) ()(2)&ABABSCIA.ResultB.Key&pointKey&pointKey&point&Key&point&C.ResultDiscussion()discussion(1)??(2)??(3)DiscussionD.Materials&&&MethodsMaterials&and&Methods&Materials&and&MethodsE.Introductionintroduction&hypothesisF. ReferenceAcknowledgeTitleAbstractG. 12345/6781Idea23&&45123413~42Introduction3456SummaryAbstractReviewer Check List: 12345/678&& IEEE Transactions on CSVT Review form: 123456//78Reviewer(Accept/Accept after a minor revision /Reject/Reject but resubmit after a major revision / Submit to another journal)1&&aXbABcABdDeDABfDABgDEhDiDjk2a30%70%bcdeReviewer&/&boss&/&colleagues&/&proof-readerf&&&3&&&5gh3a//b/cde1Abstract&&ab2Introduction&&aXbABcABdDeDABfDABg3Previous&Work&&ab()cde4Our Work&&abcde5Experiments&&abcd6Conclusion&&abc7References&&ab8Others&&1(70%)2Reviewer3(//)4123445
录入：zhousj |
相关新闻 & & &}